Variant report
Variant | esv3457692 |
---|---|
Chromosome Location | chr2:50134697-50135537 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs549542894 | chr2:50134729-50134730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs34491595 | chr2:50134762-50134763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs115262772 | chr2:50134807-50134808 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs72885847 | chr2:50134844-50134845 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs553985782 | chr2:50134846-50134847 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs534124554 | chr2:50134852-50134853 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs76155217 | chr2:50134856-50134857 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs566761139 | chr2:50134936-50134937 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs144428326 | chr2:50134946-50134947 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs568712730 | chr2:50135009-50135010 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs555625613 | chr2:50135050-50135051 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs373756139 | chr2:50135076-50135077 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs574158400 | chr2:50135078-50135079 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs187875966 | chr2:50135125-50135126 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556808171 | chr2:50135140-50135141 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs13025974 | chr2:50135149-50135150 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs148410894 | chr2:50135159-50135160 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs545782943 | chr2:50135192-50135193 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs76937643 | chr2:50135238-50135239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs111805776 | chr2:50135261-50135262 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs558144843 | chr2:50135299-50135300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs147600113 | chr2:50135303-50135304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs528565872 | chr2:50135304-50135305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs140503608 | chr2:50135305-50135306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs549432013 | chr2:50135311-50135312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs571113278 | chr2:50135321-50135322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs532133944 | chr2:50135352-50135353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs116372864 | chr2:50135353-50135354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs547398776 | chr2:50135361-50135362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs565959682 | chr2:50135402-50135403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs562229087 | chr2:50135436-50135437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs193049699 | chr2:50135460-50135461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs533964971 | chr2:50135463-50135464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs13000689 | chr2:50135464-50135465 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs72885848 | chr2:50135483-50135484 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs78830755 | chr2:50135501-50135502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs556650614 | chr2:50135509-50135510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs377292637 | chr2:50135510-50135511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Psychiatric disorder | 19734545 | CNVD |
Autism | 20844286 | CNVD |
Schizophrenia | 20838587 | CNVD |
Schizophrenia | 20718829 | CNVD |
Autism | 19218893 | CNVD |
Autism | 22209245 | CNVD |
Neuropsychiatric disorder | 21827697 | CNVD |
Schizophrenia | 22118685 | CNVD |
Autism | 20663923 | CNVD |
Schizophrenia | 21285140 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21990379 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:50131000-50137000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
2 | chr2:50132200-50134800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr2:50134800-50135200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr2:50135200-50136800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |